| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2004 | CN1506057A Cell growth regulating factor Q and its prepn process |
| 06/23/2004 | CN1506056A Cell growth regulating factor R and its prepn process |
| 06/23/2004 | CN1506055A Cell growth regulatnig factor S and its prepn process |
| 06/23/2004 | CN1506054A Cell growth regulating factor U and its prepn process |
| 06/23/2004 | CN1506053A Cell growth regulating factor W and its prepn process |
| 06/23/2004 | CN1506052A Cell growth regulating factor X and its prepn process |
| 06/23/2004 | CN1506051A Antitumor use of diosgenin |
| 06/23/2004 | CN1506050A Prepn process of Xuesaitong guttate pills |
| 06/23/2004 | CN1506049A Medicine for treating diabetes and its complication |
| 06/23/2004 | CN1506048A Application of levo histidine in treating diabetes |
| 06/23/2004 | CN1506047A Effervescent vitamin C granule and its prepn |
| 06/23/2004 | CN1506046A Active compound of Baojiwan pill for resisting diarrhea and reducing gastrointestinal illness |
| 06/23/2004 | CN1506045A P-ethyl phenol aminophenol anal injection for children and its prepn |
| 06/23/2004 | CN1506038A Oral hygienic product with melatonin alkali as active substance to supply human and animal use |
| 06/23/2004 | CN1506035A Hair conditioning composition containing film forming gradient copolymer, airsol composition containing the same hair care composition and treatment method |
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154730C Compounds and methods for diagnosis of tuberculosis |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154653C Peptide and method of obtaining it |
| 06/23/2004 | CN1154652C 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
| 06/23/2004 | CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same |
| 06/23/2004 | CN1154649C Novel C-2 5/0-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta lactamase inhibitors |
| 06/23/2004 | CN1154648C Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154645C S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 06/23/2004 | CN1154644C Oxazolidinone derivatives and pharmaceutical compositions |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/23/2004 | CN1154641C Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof |
| 06/23/2004 | CN1154638C Method for control of arthropods in animals |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154632C Amino alcohol derivs, method of producing said derivs, and medicaments contg. them |
| 06/23/2004 | CN1154512C Polymeric derivatives of camptothecins |
| 06/23/2004 | CN1154511C Oil-in-water emulsion exhibiting protective action against damages to human organs resultnig from peroxidation and prodn, and use thereof |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154506C Method of preventing or treating allergies |
| 06/23/2004 | CN1154505C Use of gastrointstinal lipase inhibitors |
| 06/23/2004 | CN1154501C Substance for preparing medicine to promote union of bone fracture and its preparing process |
| 06/23/2004 | CN1154500C Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition |
| 06/23/2004 | CN1154499C 13-Deoxyanthracycline derivatives and processes for preparing them |
| 06/23/2004 | CN1154498C Process for preparation of oral pharmaceutical compositions comprising biphosphonates |
| 06/23/2004 | CN1154497C Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 06/23/2004 | CN1154496C Application of Odanpine of fluoxetine in medicine for treatment of refractory depression |
| 06/23/2004 | CN1154495C Use of mirtazapine for treating sleep apneas |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154493C Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antivirual agents containing both |
| 06/23/2004 | CN1154492C Medical composition containing pentosan polysulfate and its application |
| 06/23/2004 | CN1154491C Method for improving pharmacokinetics of tipranavir |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/23/2004 | CN1154488C Immuno inhibitort |
| 06/23/2004 | CN1154487C Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 06/23/2004 | CN1154486C Application of thyroxine analogues method of treating malignant tumours with thyroxine analogues having no significant hormonal activity |
| 06/23/2004 | CN1154485C Use of a specific antagonist of 5HTz receptors for preparing medicine useful for treating sleep-disordered breathing |
| 06/23/2004 | CN1154484C Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 06/23/2004 | CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation |
| 06/23/2004 | CN1154482C Particles coated with granulated crystalline ibuprofen |
| 06/23/2004 | CN1154481C Taste masked pharmaceutical compositions |
| 06/23/2004 | CN1154480C Process for making flurbiprofen lozenges |
| 06/23/2004 | CN1154477C Pressurized metered dose inhalers and pharmaceutical aerosol formulations |
| 06/23/2004 | CN1154476C Improved fast disintegrating tablet |
| 06/23/2004 | CA2451179A1 Alpha glucosidase inhibitor use |
| 06/22/2004 | US6753445 14-o-((cycloalkyl-sulfanyl)acetyl)-, 14-o-((cycloalkyl-alkyl-sulfanyl)acetyl)-, 14-o-((cycloalkoxy)acetyl)- and 14-o-((cycloalkyl-alkoxy) acetyl) mutilins; microbiocides |
| 06/22/2004 | US6753442 Amorphous nitric esters and their pharmaceutical compositions |
| 06/22/2004 | US6753432 Process for the preparation of thiazolidinedione derivatives |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/22/2004 | US6753350 Method to reduce the incidence of intraventricular hemorrhage in preterm infants |
| 06/22/2004 | US6753348 Bruton's tyrosine kinase; contacting mast cells with a leukotriene altering amount of a leflunomide analog |
| 06/22/2004 | US6753347 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 06/22/2004 | US6753346 CETP activity inhibitor |
| 06/22/2004 | US6753345 7-hexanolytaxol and methods for preparing the same |
| 06/22/2004 | US6753342 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 06/22/2004 | US6753341 Administering a bis (indolyl) maleimide protein kinase c (pkc) inhibitor in peritoneal dialysis fluid |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753338 Also useful for treatment of angina, as a calcium channel antagonist such as cerebral ischemia, cerebral disorders, arrhythmias, without concomitant liability of adverse effects associated with racemic mixture of amlodipine |
| 06/22/2004 | US6753337 Inhibitors of tnf-alpha converting enzyme; treatment of arthritis, inflammation, inflammatory bowel disease etc, |
| 06/22/2004 | US6753336 Melanin concentrating hormone receptor ligands |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753334 Preparing a phenyl or quinolinyl hydrazine by reducing the corresponding diazonium salt with ascorbic acid and heating; colorless product; intermediates to drugs for reducing tissue damage from ischemia or hypoxia |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/22/2004 | US6753330 2-benzyl-5-(4-chlorophenyl)-6-(4-(methylthio)phenyl)-2h -pyridazin-3-one, hydroxypropylmethylcellulose, and ethylene oxide-propylene oxide copolymer; interleukin inhibitors; rheumatic diseases |
| 06/22/2004 | US6753328 Liver cancer; administering taurolidine |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753326 14, 15-.α.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | US6753323 For protecting mucosal, skin, or hair tissue from damage by radiation and chemotherapeutic agents; side effects reduction |
| 06/22/2004 | US6753319 Prevent coupling of sperm and egg |
| 06/22/2004 | US6753316 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents |
| 06/22/2004 | US6753315 Locally administering to a cutaneous tissue an isolated native or modified alpha -bungarotoxin molecule (a polypeptide) to enhance denervation of the muscle to enhance relaxation or slackening of the cutaneous tissue |
| 06/22/2004 | US6753298 Agents for combating Neospora spec |
| 06/22/2004 | US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator |
| 06/22/2004 | US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 06/22/2004 | US6753021 Biologically active chloroform fraction of an extract obtained from a mangrove plant Salvadora persica L |
| 06/22/2004 | US6753013 Vitamin d or vitamin d analogue; a corticosteroid; solvent; topical |
| 06/22/2004 | US6753009 Soft tablet containing high molecular weight polyethylene oxide |
| 06/22/2004 | US6752999 Prophylaxis of erythema induced by exposure to ultraviolet or solar radiation by applying formulation containing lipoic acid in dermatologically acceptable carrier to exposed skin tissue |